For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Braskem S.A. ADR’s stock clocked out at $2.64, down -2.94% from its previous closing price of $2.72. In other words, the price has decreased by -$2.94 from its previous closing price. On the day, 0.86 million shares were traded. BAK stock price reached its highest trading level at $2.7393 during the session, while it also had its lowest trading level at $2.63.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 1093714944 and an Enterprise Value of 57717628928. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.03. Its current Enterprise Value per Revenue stands at 0.743 whereas that against EBITDA is 23.674.
Stock Price History:
The Beta on a monthly basis for BAK is 1.82, which has changed by -0.5562806 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, BAK has reached a high of $6.34, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is -9.81%, while the 200-Day Moving Average is calculated to be -25.28%.
Shares Statistics:
It appears that BAK traded 1.05M shares on average per day over the past three months and 1016710 shares per day over the past ten days. A total of 172.53M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of 1760486400 were 2972780 with a Short Ratio of 2.82, compared to 1757894400 on 3161073. Therefore, it implies a Short% of Shares Outstanding of 2972780 and a Short% of Float of 3.1300000000000003.
Earnings Estimates
. The current assessment of Braskem S.A. ADR (BAK) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$1.19, with high estimates of -$1.19 and low estimates of -$1.19.
Analysts are recommending an EPS of between $0.4 and -$0.51 for the fiscal current year, implying an average EPS of -$0.06. EPS for the following year is -$0.65, with 2.0 analysts recommending between -$0.48 and -$0.83.
Revenue Estimates
In. The current quarter, 5 analysts expect revenue to total $18.03B. It ranges from a high estimate of $19.92B to a low estimate of $16.45B. As of. The current estimate, Braskem S.A. ADR’s year-ago sales were $21.27BFor the next quarter, 5 analysts are estimating revenue of $17.78B. There is a high estimate of $18.23B for the next quarter, whereas the lowest estimate is $17.12B.
A total of 10 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $77.08B, while the lowest revenue estimate was $69.97B, resulting in an average revenue estimate of $74.32B. In the same quarter a year ago, actual revenue was $77.41BBased on 10 analysts’ estimates, the company’s revenue will be $81.1B in the next fiscal year. The high estimate is $90.67B and the low estimate is $73.91B.
